PPARA and metabolic disease: As endocrine-disrupting chemicals, PFAS disrupt metabolic and hormonal homeostasis via pathways such as PPAR activation and can induce epigenetic alterations, leading to metabolic disorders, inflammation, and potential carcinogenic risks.